TABLE 1.

Patient accountability by country in ITT and PP populations^a

Study population	DHA/PQP dispersible-tablet group				DHA/PQP crushed-tablet group
	ITT		PP		ITT		PP
	n	%	n	%	n	%	n	%
Total	199	100	173	100	99	100	84	100
Mozambique	90	45.2	83	48.0	51	51.5	40	47.6
Gambia	11	5.5	6	3.5	3	3.0	3	3.6
DR-Congo	26	13.1	25	14.5	7	7.1	7	8.3
Burkina Faso	67	33.7	57	33.0	37	37.4	33	39.3
Tanzania	5	2.51	2	1.2	1	1.0	1	1.2

^an, number of patients. DR-Congo, Democratic Republic of the Congo.